Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DANAHER CORP /DE/DHR · Entity 2871 | Director | July 31, 2026 | August 04, 2026 |
| Structure Therapeutics Inc.GPCR · Entity 1222 | Director · CHIEF EXECUTIVE OFFICER | March 19, 2026 | March 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DANAHER CORP /DE/
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom sharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,427.835 |
Reported balance
After 2026-07-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-31 · Grant · Acquired 181.549 · Balance 7,427.835 F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3: The reporting person is fully vested in all amounts deferred under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.
F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.
F3: The reporting person is fully vested in all amounts deferred under the Plan.
Structure Therapeutics Inc.
Report date March 19, 2026 · Filed March 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,401,593 |
Reported balance
After 2026-03-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-19 · Grant · Acquired 260,217 · Balance 1,401,593 F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.82 · Expires 2036-03-18 | Direct | 322,230 |
Reported balance
After 2026-03-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-19 · Grant · Acquired 322,230 · Balance 322,230 F4: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F5: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. |
| Ordinary SharesSEC Table I · non-derivative | IndirectSee footnote | 1,554,586 |
Reported balance
Holding disclosure · report date 2026-03-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,554,586 F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F3: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates.
F3: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.
F4: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F5: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 4, 2026 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 181.549 | $194.98 Strike: $0.00 | $35,398.42 |
DisclosureSEC source: 0000313616-26-000165 · wk-form4_1785877231.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,427.835 Underlying: Common Stock · 181.549 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:09 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,699 | $0.00 Strike: $161.91 | $0.00 |
DisclosureSEC source: 0000313616-26-000145 · wk-form4_1779224996.xml · derivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,699 Underlying: Common Stock · 1,699 shares Expires 2036-05-15 Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:09 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-26-000145 · wk-form4_1779224996.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,728.286 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 199.26 | $177.25 Strike: $0.00 | $35,318.84 |
DisclosureSEC source: 0000313616-26-000123 · wk-form4_1777410066.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,246.286 Underlying: Common Stock · 199.26 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 20:30 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantEmployee Stock Option (right to buy) · Derivative | 322,230 | $0.00 Strike: $16.82 | $0.00 |
DisclosureSEC source: 0001698149-26-000003 · form4-03232026_040301.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,230 Underlying: Ordinary Shares · 322,230 shares Expires 2036-03-18 F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 20:30 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 260,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001698149-26-000003 · form4-03232026_040301.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,401,593 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:20 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 53,454 | $20.99 | $1,121,999.46 |
DisclosureSEC source: 0001698149-26-000002 · form4-03052026_060301.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,141,376 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 22:25 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 158.547 | $218.89 Strike: $0.00 | $34,704.35 |
DisclosureSEC source: 0000313616-26-000012 · wk-form4_1770157550.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,047.026 Underlying: Common Stock · 158.547 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| November 20, 2025 Filed Mar 5, 2026 23:20 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantAmerican Depositary Shares · Derivative | 824 | $0.00 | $0.00 |
DisclosureSEC source: 0001698149-26-000002 · form4-03052026_060301.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,824 Underlying: Ordinary Shares · 2,472 shares Expires not disclosed F4 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · kind: Voluntary reporting of the acquisition of 824 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan. F4 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F4 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 22:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 160.891 | $215.38 Strike: $0.00 | $34,652.70 |
DisclosureSEC source: 0000313616-25-000194 · wk-form4_1762207275.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,888.48 Underlying: Common Stock · 160.891 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 21:07 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 168.381 | $205.48 Strike: $0.00 | $34,598.93 |
DisclosureSEC source: 0000313616-25-000168 · wk-form4_1753736813.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,727.588 Underlying: Common Stock · 168.381 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 21:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 16,050 | $6.84 | $109,727.43 |
DisclosureSEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,194,830 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 21:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 89,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,210,880 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F3 · kind: On March 15, 2024, the reporting person was granted performance-vesting restricted share units ("PSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date. Read SEC document |
| May 21, 2025 Filed Jul 3, 2025 21:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantAmerican Depositary Shares · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019350 · form4-07032025_050702.xml · derivative · entry 5 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Ordinary Shares · 3,000 shares Expires not disclosed F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F6 · kind: Voluntary reporting of the acquisition of 1,000 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan. F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,478 | $0.00 Strike: $190.95 | $0.00 |
DisclosureSEC source: 0000313616-25-000136 · wk-form4_1747688532.xml · derivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,478 Underlying: Common Stock · 1,478 shares Expires 2035-05-15 Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 577 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-25-000136 · wk-form4_1747688532.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,361.207 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 175.22 | $197.14 Strike: $0.00 | $34,542.87 |
DisclosureSEC source: 0000313616-25-000101 · wk-form4_1745960444.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,559.207 Underlying: Common Stock · 175.22 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantEmployee Stock Option (right to buy) · Derivative | 826,890 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008550 · form4-03182025_080301.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 826,890 Underlying: Ordinary Shares · 826,890 shares Expires 2035-03-14 F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 00:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 340,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008550 · form4-03182025_080301.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,133,678 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 21:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 12,495 | $7.92 | $98,917.92 |
DisclosureSEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,121,183 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:36 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 147.858 | $222.74 Strike: $0.00 | $32,933.89 |
DisclosureSEC source: 0000313616-25-000035 · wk-form4_1738708572.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,383.987 Underlying: Common Stock · 147.858 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| October 25, 2024 Filed Oct 28, 2024 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 134.062 | $245.39 Strike: $0.00 | $32,897.47 |
DisclosureSEC source: 0000313616-24-000234 · wk-form4_1730149241.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,236.129 Underlying: Common Stock · 134.062 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 26, 2024 Filed Jul 29, 2024 21:01 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 119.985 | $273.19 Strike: $0.00 | $32,778.70 |
DisclosureSEC source: 0000313616-24-000205 · wk-form4_1722286855.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,102.067 Underlying: Common Stock · 119.985 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 50,001 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 5 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,766 Underlying: Ordinary Shares · 50,001 shares Expires 2031-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares vest in a series of 48 successive equal monthly installments beginning one month after January 22, 2021. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionShare Option (right to buy) · Derivative | 99,999 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 4 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1 Underlying: Ordinary Shares · 99,999 shares Expires 2030-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 50,001 | $0.48 | $24,000.48 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 793,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:19 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Exercise / conversionOrdinary Shares | 99,999 | $0.39 | $38,999.61 |
DisclosureSEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:42 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 185,000 | $52.80 | $9,767,352.50 |
DisclosureSEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 4 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 555,000 shares Expires not disclosed F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · price: The weighted average sale price for the transaction was $52.7965, and the range of prices was $52.43 and $53.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:42 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 185,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Ordinary Shares · 555,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:42 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 555,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016510 · form4-06122024_080615.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II above. Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:10 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,081 | $0.00 Strike: $263.46 | $0.00 |
DisclosureSEC source: 0000313616-24-000166 · wk-form4_1715980200.xml · derivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,081 Underlying: Common Stock · 1,081 shares Expires 2034-05-15 Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:10 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-24-000166 · wk-form4_1715980200.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,207.082 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 26, 2024 Filed Apr 29, 2024 21:00 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 133.139 | $246.58 Strike: $0.00 | $32,829.41 |
DisclosureSEC source: 0000313616-24-000122 · wk-form4_1714424448.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,982.082 Underlying: Common Stock · 133.139 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:36 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantStock Option (right to buy) · Derivative | 335,481 | $0.00 Strike: $35.25 | $0.00 |
DisclosureSEC source: 0001415889-24-008561 · form4-03192024_080344.xml · derivative · entry 3 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,481 Underlying: Ordinary Shares · 335,481 shares Expires 2034-03-14 F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:36 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 134,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008561 · form4-03192024_080344.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,198,346 F1 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 23:34 UTC Amendment | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantStock Option (right to buy) · Derivative | 335,481 | $0.00 Strike: $11.75 | $0.00 |
DisclosureSEC source: 0001415889-24-008780 · form4a-03202024_110300.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,481 Underlying: Ordinary Shares · 335,481 shares Expires 2034-03-14 F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares ("ADSs"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F3 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 22:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 140.001 | $233.00 Strike: $0.00 | $32,620.23 |
DisclosureSEC source: 0000313616-24-000022 · wk-form4_1706652373.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,848.943 Underlying: Common Stock · 140.001 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| October 27, 2023 Filed Oct 30, 2023 21:02 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 174.283 | $187.88 Strike: $0.00 | $32,744.29 |
DisclosureSEC source: 0000313616-23-000272 · wk-form4_1698699747.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,708.941 Underlying: Common Stock · 174.283 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 125.134 | $260.07 Strike: $0.00 | $32,543.60 |
DisclosureSEC source: 0000313616-23-000242 · wk-form4_1690923966.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,916.289 Underlying: Common Stock · 125.134 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:05 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantDirector stock option (right to buy) · Derivative | 1,194 | $0.00 Strike: $226.94 | $0.00 |
DisclosureSEC source: 0000313616-23-000204 · wk-form4_1684357510.xml · derivative · entry 2 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,194 Underlying: Common Stock · 1,194 shares Expires 2033-05-15 Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:05 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-23-000204 · wk-form4_1684357510.xml · nonDerivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,083.155 F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 137.211 | $236.91 Strike: $0.00 | $32,506.66 |
DisclosureSEC source: 0000313616-23-000163 · wf-form4_168297519032863.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,791.155 Underlying: Common Stock · 137.211 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 23:58 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | PurchaseAmerican Depositary Shares · Derivative | 4,000 | $15.00 | $60,000.00 |
DisclosureSEC source: 0001209191-23-008159 · doc4.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,000 Underlying: Ordinary Shares · 12,000 shares Expires not disclosed F1 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F2 · kind: The American Depositary Shares were purchased in the Issuer's initial public offering. F1 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F1 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F3 · ownership.nature: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantStock option (right to buy) · Derivative | 1,600,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007314 · doc4.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Ordinary Shares · 1,600,000 shares Expires 2033-02-01 F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the first anniversary of February 2, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 22:08 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GrantPhantom shares · Derivative | 121.75 | $265.98 Strike: $0.00 | $32,383.07 |
DisclosureSEC source: 0000313616-23-000042 · wf-form4_167511647348898.xml · derivative · entry 1 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,653.944 Underlying: Common Stock · 121.75 shares Expires not disclosed F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis. F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan. F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan. F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 2,230 | $0.00 Strike: $131.05 | $0.00 |
DisclosureSEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · derivative · entry 9 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,230 shares Expires 2029-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 2,640 | $0.00 Strike: $100.24 | $0.00 |
DisclosureSEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · derivative · entry 8 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,640 shares Expires 2028-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionDirector stock option (right to buy) · Derivative | 3,540 | $0.00 Strike: $83.28 | $0.00 |
DisclosureSEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · derivative · entry 7 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,540 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 2,230 | $264.24 | $589,244.05 |
DisclosureSEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · nonDerivative · entry 6 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,394.194 Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 2,230 | $131.05 | $292,241.50 |
DisclosureSEC source: 0000313616-23-000008 · wf-form4_167477074086572.xml · nonDerivative · entry 5 Stevens Raymond C · CIK 0001698149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,624.194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.